Reply to letter to editor "public health impact and cost-effectiveness of the adjuvanted RSVPreF3 vaccine for respiratory syncytial virus prevention among adults aged 50 years and older in Germany" [0.03%]
关于《RSVPreF3佐剂疫苗在德国50岁以上成人中预防呼吸道合胞病毒的公共卫生影响和成本效益》一文的回信
Maria Waize,Pavo Marijic,Alen Marijam et al.
Maria Waize et al.
Global status of HPV vaccination two decades in: effective, safe and preventing cancer [0.03%]
全球HPV疫苗接种现状：二十余年的成效、安全及癌症预防作用
Julia M L Brotherton,D Scott La Montagne,Paul J N Bloem
Julia M L Brotherton
Introduction: Prophylactic human papillomavirus vaccines have been in use in populations worldwide for nearly 20 years. Much has been learnt in relation to their effectiveness, safety and how best to effectively implement...
Exploring determinants of vaccine hesitancy among healthcare professionals: a systematic literature review [0.03%]
探索医疗专业人员疫苗犹豫不决的影响因素：系统文献回顾
Valeria Gabellone,Fabiana Nuccetelli,Elisa Gabrielli et al.
Valeria Gabellone et al.
Introduction: This systematic review aims to assess determinants of vaccine hesitancy (VH) among healthcare professionals, to identify knowledge gaps and inform targeted training programs. ...
A human Lyme disease vaccine: two steps forward on the path to prevention [0.03%]
一种人类莱姆病疫苗：通向预防的道路上迈出的两步进展
Raphael Simon,Erik Lamberth,James H Stark et al.
Raphael Simon et al.
Introduction: Lyme disease is caused by the tick-borne spirochete pathogen Borrelia burgdorferi sensu lato (s.l.). Outer surface protein A (OspA) is expressed by B. burgdorferi s.l. while in the tick and antibodies agains...
Letter to the editor: public health impact and cost-effectiveness of the adjuvanted RSVPreF3 vaccine for respiratory syncytial virus prevention among adults aged 50 years and older in Germany [0.03%]
写给德国编辑的一封信：RSVPreF3疫苗对50岁及以上成年人预防呼吸道合胞病毒的公共卫生影响和成本效益
Jannik Stemler,Sebastian Herrmann,Oliver Cornely et al.
Jannik Stemler et al.
Pneumococcal conjugate vaccines in older adults and immunocompromised individuals [0.03%]
肺炎球菌结合疫苗在老年人和免疫缺陷人群中的应用
Viravarn Luvira,Thundon Ngamprasertchai,Punnee Pitisuttithum
Viravarn Luvira
Introduction: Pneumococcal disease leads to high morbidity and mortality, particularly in older adults and immunocompromised individuals. Many pneumococcal conjugated vaccines (PCVs) have become available. However, the im...
Herpes zoster vaccine awareness and determinants among Chinese adults aged ≥60 years: a cross-sectional study [0.03%]
中国老年人带状疱疹疫苗认知及影响因素的横断面研究
Jianing Dai,Yuxing Wang,Shuai Yuan et al.
Jianing Dai et al.
Background: In China, low awareness of the herpes zoster vaccine (HZV) hinders vaccination uptake among older adults. This study aimed to investigate HZV awareness rates and associated factors among older urban Chinese ad...
Jean Haensler,Luc Even,Pierre Wils et al.
Jean Haensler et al.
Introduction: One of the biggest challenges in the mRNA-LNP vaccine field is product stabilization to overcome the logistical hurdles linked to the ultra-cold distribution chain associated with first-generation mRNA SARS-...
Antigenic drift in SARS-CoV-2: diminished vaccine protection in pediatric populations against omicron and its JN.1 subvariant [0.03%]
新型冠状病毒(SARS-CoV-2)的抗原漂变导致疫苗对儿童感染奥密克戎及其JN.1亚型的预防效果减弱
Jéssica Pires Farias,Milena Silva Souza,Mayanna Moreira Costa Fogaça et al.
Jéssica Pires Farias et al.
Background: The COVID-19 vaccination campaign for children in Brazil evolved gradually from 2021 to the present, adapting to regulatory framework from the Brazilian Health Regulatory Agency (ANVISA). However, while adults...
Contextual adaptation and validation of the international pro-VC-Be tool for measuring healthcare worker vaccine confidence in Nigeria [0.03%]
尼日利亚医务人员疫苗信心的国际测量工具的地方适应性和验证
Julius Salako,Damola Bakare,Kofoworola O Akinsola et al.
Julius Salako et al.
Background: Vaccine hesitancy amongst healthcare workers (HCWs) is a global concern, needing reliable tools to measure HCW vaccine confidence. We adapted and validated the 10-item 'iPro-VC-Be' tool for the Nigerian contex...